Legacy Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $5.85M | Buy |
|
|||||
|
2021
Q4 | $4.95M | Sell |
|
|||||
|
2021
Q3 | $4.8M | Sell |
|
|||||
|
2021
Q2 | $5.5M | Buy |
|
|||||
|
2021
Q1 | $4.96M | Buy |
|
|||||
|
2020
Q4 | $3.4M | Sell |
|
|||||
|
2020
Q3 | $3.64M | Buy |
|
|||||
|
2020
Q2 | $3.37M | Buy |
|
|||||
|
2020
Q1 | $3.16M | Sell |
|
|||||
|
2019
Q4 | $3.81M | Buy |
|
|||||
|
2019
Q3 | $2.22M | Buy |
|
|||||
|
2019
Q2 | $1.27M | Buy |
|
|||||
|
2019
Q1 | $383K | Hold |
|
|||||
|
2018
Q4 | $418K | Hold |
|
|||||
|
2018
Q3 | $499K | Sell |
|
|||||
|
2018
Q2 | $450K | Sell |
|
|||||
|
2018
Q1 | $679K | Sell |
|
|||||
|
2017
Q4 | $658K | Sell |
|
|||||
|
2017
Q3 | $685K | Buy |
|
|||||
|
2017
Q2 | $562K | Buy |
|
|||||
|
2017
Q1 | $530K | Buy |
|
|||||
|
2016
Q4 | $476K | Buy |
|
|||||
|
2016
Q3 | $350K | Sell |
|
|||||
|
2016
Q2 | $624K | Sell |
|
|||||
|
2016
Q1 | $566K | Sell |
|
|||||
|
2015
Q4 | $637K | Hold |
|
|||||
|
2015
Q3 | $548K | Sell |
|
|||||
|
2015
Q2 | $683K | Sell |
|
|||||
|
2015
Q1 | $668K | Sell |
|
|||||
|
2014
Q4 | $623K | Hold |
|
|||||
|
2014
Q3 | $540K | Hold |
|
|||||
|
2014
Q2 | $512K | Hold |
|
|||||
|
2014
Q1 | $549K | Sell |
|
|||||
|
2013
Q4 | $572K | Hold |
|
|||||
|
2013
Q3 | $498K | Sell |
|
|||||
|
2013
Q2 | $482K | Buy |
|